315 related articles for article (PubMed ID: 25244509)
21. Intestinal dysbiosis and probiotic applications in autoimmune diseases.
de Oliveira GLV; Leite AZ; Higuchi BS; Gonzaga MI; Mariano VS
Immunology; 2017 Sep; 152(1):1-12. PubMed ID: 28556916
[TBL] [Abstract][Full Text] [Related]
22. Gut microbiome in chronic kidney disease: challenges and opportunities.
Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D
Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743
[TBL] [Abstract][Full Text] [Related]
23. Restoration of dysbiotic human gut microbiome for homeostasis.
Dixit K; Chaudhari D; Dhotre D; Shouche Y; Saroj S
Life Sci; 2021 Aug; 278():119622. PubMed ID: 34015282
[TBL] [Abstract][Full Text] [Related]
24. The gastrointestinal microbiome and musculoskeletal diseases: a beneficial role for probiotics and prebiotics.
Vitetta L; Coulson S; Linnane AW; Butt H
Pathogens; 2013 Nov; 2(4):606-26. PubMed ID: 25437335
[TBL] [Abstract][Full Text] [Related]
25. Non-celiac gluten sensitivity triggers gut dysbiosis, neuroinflammation, gut-brain axis dysfunction, and vulnerability for dementia.
Daulatzai MA
CNS Neurol Disord Drug Targets; 2015; 14(1):110-31. PubMed ID: 25642988
[TBL] [Abstract][Full Text] [Related]
26. The Gastrointestinal Microbiome: Alcohol Effects on the Composition of Intestinal Microbiota.
Engen PA; Green SJ; Voigt RM; Forsyth CB; Keshavarzian A
Alcohol Res; 2015; 37(2):223-36. PubMed ID: 26695747
[TBL] [Abstract][Full Text] [Related]
27. The potential impact of gut microbiota on your health:Current status and future challenges.
Sirisinha S
Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
[TBL] [Abstract][Full Text] [Related]
28. The influence of the commensal microbiota on distal tumor-promoting inflammation.
Buchta Rosean CM; Rutkowski MR
Semin Immunol; 2017 Aug; 32():62-73. PubMed ID: 28687194
[TBL] [Abstract][Full Text] [Related]
29. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics.
Plaza-Diaz J; Gomez-Llorente C; Fontana L; Gil A
World J Gastroenterol; 2014 Nov; 20(42):15632-49. PubMed ID: 25400447
[TBL] [Abstract][Full Text] [Related]
30. [Significance and effects of prenatal and postnatal microbiome in the period of early individual development and options for interventional treatment].
Fülöp V; Demeter J; Cseh Á
Orv Hetil; 2021 May; 162(19):731-740. PubMed ID: 33965906
[TBL] [Abstract][Full Text] [Related]
31. Gastrointestinal tract microbiota and probiotics in production animals.
Yeoman CJ; White BA
Annu Rev Anim Biosci; 2014 Feb; 2():469-86. PubMed ID: 25384152
[TBL] [Abstract][Full Text] [Related]
32. The Immune System through the Lens of Alcohol Intake and Gut Microbiota.
Calleja-Conde J; Echeverry-Alzate V; Bühler KM; Durán-González P; Morales-García JÁ; Segovia-Rodríguez L; Rodríguez de Fonseca F; Giné E; López-Moreno JA
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299105
[TBL] [Abstract][Full Text] [Related]
33. Gut microbiota in surgical and critically ill patients.
Ho KM; Kalgudi S; Corbett JM; Litton E
Anaesth Intensive Care; 2020 May; 48(3):179-195. PubMed ID: 32131606
[TBL] [Abstract][Full Text] [Related]
34. Exercise Modifies the Gut Microbiota with Positive Health Effects.
Monda V; Villano I; Messina A; Valenzano A; Esposito T; Moscatelli F; Viggiano A; Cibelli G; Chieffi S; Monda M; Messina G
Oxid Med Cell Longev; 2017; 2017():3831972. PubMed ID: 28357027
[TBL] [Abstract][Full Text] [Related]
35. Dysbiotic events in gut microbiota: impact on human health.
Schippa S; Conte MP
Nutrients; 2014 Dec; 6(12):5786-805. PubMed ID: 25514560
[TBL] [Abstract][Full Text] [Related]
36. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
Raftery AL; Tsantikos E; Harris NL; Hibbs ML
Front Immunol; 2020; 11():2144. PubMed ID: 33042125
[TBL] [Abstract][Full Text] [Related]
37. Influences of non-IgE-mediated cow's milk protein allergy-associated gut microbial dysbiosis on regulatory T cell-mediated intestinal immune tolerance and homeostasis.
Wang J; Zheng S; Yang X; Huazeng B; Cheng Q
Microb Pathog; 2021 Sep; 158():105020. PubMed ID: 34089791
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory bowel disease, gut bacteria and probiotic therapy.
Reiff C; Kelly D
Int J Med Microbiol; 2010 Jan; 300(1):25-33. PubMed ID: 19800289
[TBL] [Abstract][Full Text] [Related]
39. Gut microbiota-derived metabolites as key mucosal barrier modulators in obesity.
Wei YX; Zheng KY; Wang YG
World J Gastroenterol; 2021 Sep; 27(33):5555-5565. PubMed ID: 34588751
[TBL] [Abstract][Full Text] [Related]
40. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases.
Lin L; Zhang J
BMC Immunol; 2017 Jan; 18(1):2. PubMed ID: 28061847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
